HUP0102741A3 - Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates - Google Patents

Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates

Info

Publication number
HUP0102741A3
HUP0102741A3 HU0102741A HUP0102741A HUP0102741A3 HU P0102741 A3 HUP0102741 A3 HU P0102741A3 HU 0102741 A HU0102741 A HU 0102741A HU P0102741 A HUP0102741 A HU P0102741A HU P0102741 A3 HUP0102741 A3 HU P0102741A3
Authority
HU
Hungary
Prior art keywords
macromolecules
associates
controllable
developing
testing
Prior art date
Application number
HU0102741A
Other languages
English (en)
Original Assignee
Idea Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idea Ag filed Critical Idea Ag
Publication of HUP0102741A2 publication Critical patent/HUP0102741A2/hu
Publication of HUP0102741A3 publication Critical patent/HUP0102741A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HU0102741A 1998-10-23 1998-10-23 Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates HUP0102741A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1998/006750 WO2000024377A1 (en) 1998-10-23 1998-10-23 Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates

Publications (2)

Publication Number Publication Date
HUP0102741A2 HUP0102741A2 (hu) 2002-03-28
HUP0102741A3 true HUP0102741A3 (en) 2002-12-28

Family

ID=8167110

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102741A HUP0102741A3 (en) 1998-10-23 1998-10-23 Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates

Country Status (13)

Country Link
US (2) US20080279815A1 (hu)
EP (1) EP1039880A1 (hu)
JP (1) JP4838936B2 (hu)
KR (1) KR100464601B1 (hu)
CN (1) CN1192766C (hu)
AU (1) AU765385C (hu)
BR (1) BR9814415A (hu)
CA (1) CA2309633C (hu)
HK (1) HK1032745A1 (hu)
HU (1) HUP0102741A3 (hu)
MX (1) MXPA00006196A (hu)
NO (1) NO20003287L (hu)
WO (1) WO2000024377A1 (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2173678T3 (es) 1999-01-27 2002-10-16 Idea Ag Vacunacion no invasiva a traves de la piel.
DK1031347T3 (da) 1999-01-27 2002-07-08 Idea Ag Transnasal transport/immunisering med meget tilpasselige bærere
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
GB2398495B (en) * 2003-01-23 2007-08-22 Kent G Lau A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug
UA75030C2 (en) * 2005-11-30 2006-03-15 Viktor Oleksandrovych Bykov Method for obtaining stable aqueous solutions of drugs
GB0623838D0 (en) * 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
US8962015B2 (en) 2007-09-28 2015-02-24 Sdg, Inc. Orally bioavailable lipid-based constructs
KR101801426B1 (ko) 2010-07-14 2017-12-20 인스티투트 오브 마타리아 메디카, 차이니즈 아카데미 오브 메디칼 사이언스 인슐린-지질 복합물 및 그의 제조방법과 그의 제제
US8422540B1 (en) 2012-06-21 2013-04-16 CBF Networks, Inc. Intelligent backhaul radio with zero division duplexing
KR101849441B1 (ko) 2015-03-19 2018-04-16 김태구 캔 오프너
KR20160112915A (ko) 2015-10-23 2016-09-28 김태구 캔 오프너
EP3377043A4 (en) * 2015-11-20 2019-06-26 The Regents of The University of California DEVICABLE NANOSCAL CARRIER (DNVS) FOR ADMINISTRATION THROUGH THE BLOOD-BRAIN-BARRIER, MICE AND SKIN
MX2019010852A (es) * 2017-03-13 2019-10-30 Sdg Inc Nanoparticulas a base de lipidos con estabilidad mejorada.
TWI834623B (zh) 2017-09-18 2024-03-11 美商拜耳保健有限責任公司 使用n-甲基葡糖醯胺及其衍生物以使病毒去活化之方法
WO2020031065A1 (en) * 2018-08-08 2020-02-13 3M Innovative Properties Company Therapeutic composition and related methods
KR20220118210A (ko) * 2021-02-18 2022-08-25 (주)아모레퍼시픽 트랜스퍼좀을 포함하는 난용성 효능물질 전달체
CN115350330B (zh) * 2022-09-01 2023-10-20 北京化工大学 一种负电性小分子调控的表面在蛋白差异性黏附上的应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
US5008050A (en) * 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
US4897269A (en) * 1984-09-24 1990-01-30 Mezei Associates Limited Administration of drugs with multiphase liposomal delivery system
US4937182A (en) * 1985-12-19 1990-06-26 Peralta Cancer Research Institute Method for predicting chemosensitivity of anti-cancer drugs
US5244678A (en) * 1986-01-14 1993-09-14 Ire-Celltarg S.A. Pharmaceutical composition containing a local anesthetic and/or centrally acting analgesic encapsulated in liposomes
EP0293465B1 (en) * 1986-11-28 1992-03-18 The Liposome Company, Inc. Phospholipid composition
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
US5043165A (en) * 1988-12-14 1991-08-27 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs
US5049392A (en) * 1989-01-18 1991-09-17 The Liposome Company, Inc. Osmotically dependent vesicles
EP0384040B1 (en) * 1989-02-24 1994-01-26 Agfa-Gevaert N.V. Dye-donor element for thermal dye sublimation transfer
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
WO1992003122A1 (de) * 1990-08-24 1992-03-05 Gregor Cevc Präparat zur wirkstoffapplikation in kleinsttröpfchenform
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
JP2922017B2 (ja) * 1991-03-25 1999-07-19 第一製薬株式会社 経口用脂質膜構造体
US5498420A (en) * 1991-04-12 1996-03-12 Merz & Co. Gmbh & Co. Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
GB9116610D0 (en) * 1991-08-01 1991-09-18 Danbiosyst Uk Preparation of microparticles
HUT74560A (en) * 1991-10-16 1997-01-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
EG20380A (en) * 1991-10-16 1999-02-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
ES2107668T3 (es) * 1992-07-08 1997-12-01 Dianorm G Maierhofer Gmbh Liposomas, procedimiento para su preparacion y su uso en la elaboracion de un medicamento.
CA2141192C (en) * 1992-07-28 1999-02-02 Roberta C. Bloom Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether
US5460820B1 (en) * 1993-08-03 1999-08-03 Theratech Inc Method for providing testosterone and optionally estrogen replacement therapy to women
US6027726A (en) * 1994-09-30 2000-02-22 Inex Phamaceuticals Corp. Glycosylated protein-liposome conjugates and methods for their preparation
DE69532622T2 (de) * 1994-12-07 2005-02-03 Tokyo Cosmos Electric Co. Ltd., , Hachioji Flächenheizelement zur Verwendung bei Spiegeln
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5783208A (en) * 1996-07-19 1998-07-21 Theratech, Inc. Transdermal drug delivery matrix for coadministering estradiol and another steroid
US5891472A (en) * 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
US5891467A (en) * 1997-01-31 1999-04-06 Depotech Corporation Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
US6726925B1 (en) * 1998-06-18 2004-04-27 Duke University Temperature-sensitive liposomal formulation
ES2226203T3 (es) * 1998-12-23 2005-03-16 Idea Ag Formulacion mejorada para aplicacion topica no invasiva.
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
US6562370B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
JP2002063747A (ja) * 2000-08-18 2002-02-28 Sony Corp 記録媒体および記録媒体原盤ならびに記録媒体の製造方法
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
GB0417494D0 (en) * 2004-08-05 2004-09-08 Glaxosmithkline Biolog Sa Vaccine

Also Published As

Publication number Publication date
HUP0102741A2 (hu) 2002-03-28
US20080311184A1 (en) 2008-12-18
CA2309633C (en) 2010-12-14
HK1032745A1 (en) 2001-08-03
AU765385C (en) 2004-05-20
AU1435099A (en) 2000-05-15
EP1039880A1 (en) 2000-10-04
KR100464601B1 (ko) 2004-12-31
JP2002528406A (ja) 2002-09-03
BR9814415A (pt) 2000-10-10
CA2309633A1 (en) 2000-05-04
WO2000024377A1 (en) 2000-05-04
US20080279815A1 (en) 2008-11-13
KR20010033518A (ko) 2001-04-25
CN1283107A (zh) 2001-02-07
CN1192766C (zh) 2005-03-16
NO20003287L (no) 2000-08-23
MXPA00006196A (es) 2003-07-21
JP4838936B2 (ja) 2011-12-14
NO20003287D0 (no) 2000-06-22
AU765385B2 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
HUP0102741A3 (en) Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
GB2340950B (en) Method and apparatus for automotive and other testing
AU2549899A (en) Method and apparatus for exposure, method of manufacture of exposure tool, device, and method of manufacture of device
HK1036853A1 (en) Method and apparatus for an improved interface between components
AU3640799A (en) Apparatus and method for trusted network security
PL333398A1 (en) Method of and apparatus for testing containers
EP0927880A4 (en) DEVICE AND METHOD FOR SAMPLE PREPARATION
AU2488299A (en) Method and apparatus for jitter analysis
AU2444697A (en) Method and apparatus for secure measurement certification
AU3267999A (en) Nqr testing method and apparatus
PL339080A1 (en) Method of and apparatus formonitoring pipelines for their condition by means of rotary currents
HK1040285A1 (en) Method and apparatus for testing poles.
AU2210595A (en) Method and apparatus for testing soil contamination
GB2354335B (en) Method and apparatus for automotive and other testing
AU6237299A (en) Method and apparatus for location based intercept
AU2936399A (en) Method and apparatus for performing packet based policing
AU3069299A (en) Method and apparatus for mitigating junction flows
AU2889299A (en) Formation testing apparatus and method
AU1979199A (en) Apparatus and method for detecting an interface
SG86357A1 (en) Method and apparatus for unlatching an actuator
AU3054999A (en) Method and apparatus for wafer processing, and method and apparatus for exposure
AU1411900A (en) Method and apparatus for wafer inspection
AU2075699A (en) Method and apparatus for detecting wafer
AU3087699A (en) Method and apparatus for testing surfaces
AUPP142698A0 (en) Apparatus and method for colour therapy

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees